Financial Year End | 2024-01-28 | 2023-01-29 | 2022-01-30 | 2021-01-31 | 2020-02-02 | 2019-01-31 | 2018-01-31 | 2016-12-31 |
---|---|---|---|---|---|---|---|---|
Revenue | 11.15B | 10.10B | 8.89B | 7.15B | 4.85B | 3.53B | 2.10B | 900.57M |
Cost of Revenue | 8.09B | 7.27B | 6.52B | 5.33B | 3.70B | 2.82B | 1.74B | 750.74M |
Gross Profit | 3.06B | 2.83B | 2.37B | 1.82B | 1.14B | 714.80M | 367.55M | 149.83M |
Operating Expenses | 3.05B | 2.78B | 2.45B | 1.91B | 1.40B | 982.57M | 705.40M | 257.26M |
Selling, General & Admin | 3.05B | 2.78B | 2.45B | 1.91B | 1.40B | 982.57M | 705.40M | 257.26M |
Research & Development | 30.20M | 22.40M | 14.20M | 7.40M | 8.60M | N/A | N/A | N/A |
Other Operating Expenses | 742.46M | -13.17M | 618.90M | 513.30M | 426.90M | N/A | N/A | N/A |
Operating Income | 5.39M | 55.75M | -72.18M | -90.46M | -252.73M | -267.77M | -337.85M | -107.43M |
Other Expenses / Income | 42.84M | -3.88M | -1.64M | -2.02M | 356.00K | -124.00K | -206.00K | 263.00K |
Before Tax Income | 48.23M | 51.88M | -73.82M | -92.49M | -252.37M | -267.89M | -338.06M | -107.16M |
Income Tax Expenses | 8.65M | 2.65M | 1.64M | 2.02M | -356.00K | 57.00K | N/A | N/A |
Net Income | 39.58M | 49.90M | -75.46M | -94.51M | -252.01M | -267.89M | -338.06M | -107.16M |
Interest Expenses | 3.58M | 9.29M | -1.64M | -2.02M | 356.00K | 181.00K | 556.00K | 296.00K |
Basic Shares Outstanding | 429.46M | 422.33M | 417.22M | 407.24M | 401.37M | 393.00M | 395.71M | 395.71M |
Diluted Shares Outstanding | 432.04M | 427.77M | 417.22M | 407.24M | 401.37M | 395.71M | 395.71M | 395.71M |
EBITDA | 115.08M | 139.06M | -17.17M | -54.80M | -222.08M | -244.50M | -324.96M | -101.83M |
EBITDA Margin | 1.03% | 1.38% | -0.19% | -0.77% | -4.58% | -6.92% | -15.44% | -11.31% |
EBIT | 51.81M | 61.84M | -75.46M | -94.51M | -252.01M | -267.65M | -337.50M | -106.87M |
EBIT Margin | 0.46% | 0.61% | -0.85% | -1.32% | -5.20% | -7.58% | -16.04% | -11.87% |
Financial Year End | 2024-01-28 | 2023-01-29 | 2022-01-30 | 2021-01-31 | 2020-02-02 | 2019-01-31 | 2018-01-31 | 2016-12-31 |